Cidara CEO Stein brings Trius gang, biotech vets together
This article was originally published in Scrip
Executive Summary
Everyone wondering what Jeffrey Stein would do next after Cubist Pharmaceuticals acquired Trius Therapeutics has their answer: The former Trius president and CEO will lead the antifungal startup Cidara Therapeutics and bring colleagues from his prior post and other local companies to the new venture.